Literature DB >> 11849871

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

Paolo Raggi1, Amy Boulay, Scott Chasan-Taber, Naseem Amin, Maureen Dillon, Steven K Burke, Glenn M Chertow.   

Abstract

OBJECTIVES: We sought to determine clinical and laboratory correlates of calcification of the coronary arteries (CAs), aorta and mitral and aortic valves in adult subjects with end-stage renal disease (ESRD) receiving hemodialysis.
BACKGROUND: Vascular calcification is known to be a risk factor for ischemic heart disease in non-uremic individuals. Patients with ESRD experience accelerated vascular calcification, due at least in part to dysregulation of mineral metabolism. Clinical correlates of the extent of calcification in ESRD have not been identified. Moreover, the clinical relevance of calcification as measured by electron-beam tomography (EBT) has not been determined in the ESRD population.
METHODS: We conducted a cross-sectional analysis of 205 maintenance hemodialysis patients who received baseline EBT for evaluation of vascular and valvular calcification. We compared subjects with and without clinical evidence of atherosclerotic vascular disease and determined correlates of the extent of vascular and valvular calcification using multivariable linear regression and proportional odds logistic regression analyses.
RESULTS: The median coronary artery calcium score was 595 (interquartile range, 76 to 1,600), values consistent with a high risk of obstructive coronary artery disease in the general population. The CA calcium scores were directly related to the prevalence of myocardial infarction (p < 0.0001) and angina (p < 0.0001), and the aortic calcium scores were directly related to the prevalence of claudication (p = 0.001) and aortic aneurysm (p = 0.02). The extent of coronary calcification was more pronounced with older age, male gender, white race, diabetes, longer dialysis vintage and higher serum concentrations of calcium and phosphorus. Total cholesterol (and high-density lipoprotein and low-density lipoprotein subfractions), triglycerides, hemoglobin and albumin were not significantly related to the extent of CA calcification. Only dialysis vintage was significantly associated with the prevalence of valvular calcification.
CONCLUSIONS: Coronary artery calcification is common, severe and significantly associated with ischemic cardiovascular disease in adult ESRD patients. The dysregulation of mineral metabolism in ESRD may influence vascular calcification risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849871     DOI: 10.1016/s0735-1097(01)01781-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  252 in total

Review 1.  Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment.

Authors:  M Pakkal; V Raj; G P McCann
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

Authors:  Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Eschenberg; William G Richards
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 3.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

Review 4.  Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

5.  Early and Rarely - A Unique Case of Calcification in Stage 2 Chronic Kidney Disease.

Authors:  Shivanand Sangannagouda Patil; Rangaraj Rama Lingam; Subramanyam Kasam Shetty; Deepak Kumar Pujar; Manjunath Nanjappa Cholenahally
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 6.  Screening for cardiovascular disease before kidney transplantation.

Authors:  Sneha Palepu; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2015-12-24

7.  Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.

Authors:  Ronney Shantouf; Matthew J Budoff; Naser Ahmadi; Jima Tiano; Ferdinand Flores; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2007-11-09       Impact factor: 3.754

8.  Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

Authors:  Julia Spoendlin; Julie M Paik; T Tsacogianis; Seoyoung C Kim; Sebastian Schneeweiss; Rishi J Desai
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

9.  Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Authors:  T-M Yu; C-L Lin; K-H Shu; Y-L Liu; C-H Chen; S-T Huang; C-H Kao
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

Review 10.  Coronary revascularization in end-stage renal disease.

Authors:  Khaled M Ziada
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.